392
Views
8
CrossRef citations to date
0
Altmetric
Innovation

Altitude mountain sickness among tourist populations: a review and pathophysiology supporting management with hyperbaric oxygen

, , , , , , , , & show all
Pages 197-207 | Received 06 Apr 2010, Accepted 21 May 2010, Published online: 28 Jun 2012

References

  • Domej, W., Schwaberger, G., Guger, C., Herfert, J., Haditsch, B., Foldes-Papp, Z., Tilz, G. P., 2005, Aspects and necessity of moderate-altitude research. Wiener Medizinische Wochenschrift, 155, 149–156.
  • Health, D., Williams, D., 1995, High Altitude Medicine and Pathology (Oxford: Oxford University Press).
  • Zafren, K., Honigman, B., 1997, High altitude medicine. Emergency Medicine Clinics of North America, 15, 191–222.
  • Keller, H., Maggiorini, M., Bartsch, P., Oelz, O., 1995, Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomized trial. British Medical Journal, 310, 1232.
  • Saito, S., Aso, C., Kanai, M., Takazawa, T., 2000, Experimental use of a transportable hyperbaric chamber durable for 15 psi at 3,700 meters above sea level. Wilderness & Environmental Medicine, 11, 21–24.
  • Basynat, B., Lemaster, J., Litch, J., 1999, Everest or bust: a cross sectional epidemiological study of acute mountain sickness at 4,243 meters in the Himalayas. Aviation, Space, and Environmental Medicine, 70, 867–873.
  • Houstan, C., 1985, Incidence of acute mountain sickness. American Alpine Journal, 27, 162–165.
  • Maggiorini, M., Muller, A., Muller, A., Hofstetter, D., Bartsch, P., Oelz, O., 1998, Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviation, Space, and Environmental Medicine, 69, 1186–1192.
  • Montgomery, A., Mills, J., Luce, M., 1989, Incidence of acute mountain sickness at intermediate altitude. Journal of the American Medical Association, 261, 732–734.
  • Richalet, J. P., Rivera, M., Bouchet, P., Chirinos, E., Onnen, I., Petitjean, O., Bienvenu, A., Lasne, F., Moutereau, S., Leon-Velarde, F., 2005, Acetazolamide, a treatment for chronic mountain sickness. Am J Respir Crit Care Med, 172, 1427–1433.
  • Ellsworth, A. J., Larson, E. B., Strickland, D., 1987, A randomized trial of dexamethasone and aceetazolamide for acute mountain sickness. American Journal of Medicine, 83, 1024–1030.
  • Hohenhaus, E., Niroomand, F., Goerre, S., Vock, P., Oelz, O. 1994, Bartsch, P., Nifedipine does not prevent acute mountain sickness. American Journal of Respiratory and Critical Care Medicine, 150, 857–860.
  • Burse, R. L., Landowne, M., Young, A. J., Maher, J. T., 1982, Phenytoin: ineffective against acute mountain sickness. Aviation, Space, and Environmental Medicine, 53, 221–225.
  • Bezruchka, S., 1994, Altitude Illness, Prevention and Treatment (Leicester: Cordee).
  • Curtis, R., 1995, Outdoor Action Guide to High Altitude: Acclimatization and Illnesses (Outdoor Action Program, Princeton University, Princeton NJ).
  • Ellsworth, A. J., Meyer, E. F., Larson, E. B., 1991, Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier. The Western Journal of Medicine, 154, 289–293.
  • Johnson, T.S., Rock, P.B., Fulco, C.S., Trad, L.A., Spark, R.F., Maher, J.T., 1984, Prevention of acute mountain sickness by dexamethasone. New England Journal of Medicine, 310, 683–686.
  • Hackett, P.H., Roach, R.C., Wood, R.A., Foutch, R.G., Meehan, R.T., Rennie, D., Mills Jr, W.J., 1988, Dexamethasone for prevention and treatment of acute mountain sickness. Aviation, Space, and Environmental Medicine, 59, 950–954.
  • Bernard W. N., Schalick L. M., Delaney P. A., Bernhard T. M., Delaney P. A., 1998, Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness. Aviation, Space, and Environmental Medicine, 69, 883–886.
  • Tom, P. A., Garmel, G. M., Auerbach, P. S., 1994, Environment-dependent sports emergencies. Medical Clinics of North America, 78, 305–325.
  • Staton Jr, G.W., Ingram Jr, R. H., 1993, Pulmonary edema. In: E. Rubenstein (Ed.) Scientific American Medicine (New York: Scientific American), p. 14.
  • Gensini, G. F., Conti, A. A., 2003, A historical perspective on high altitude pulmonary edema. Monaldi Archives of Chest Disease, 60, 45–47.
  • Bezruchka, S., 1992, High altitude medicine. Medical Clinics of North America, 76, 1481–1497.
  • Roach, R. C., Loeppky, J. A., Icenogle M. V., 1996, Acute mountain sickness: increased severity during simulated altitude compared with normobaric hypoxia. Journal of Applied Physiology, 81, pp. 1908–1910.
  • Chryssanthou, C., Palaia, T., Goldstein, G., Stegner, R., 1987, Increase in blood-brain barrier permeability by altitude decompression. Aviation, Space, and Environmental Medicine, 58, 1082–1086.
  • Epstein, M., Saruta, T., 1972, Effects of simulated high altitude on renin-aldosterone and Na homeostasis in normal man. Journal of Applied Physiology, 33, 204–210.
  • Magalhaes, J., Ascensao, A., Viscor, G., Soares, J., Oliveira, J., Marques, F., Duarte, J., 2004, Oxidative stress in humans during and after 4 hours of hypoxia at a simulated altitude of 5500 m. Aviation, Space, and Environmental Medicine, 75, 16–22.
  • Hackett, P. H., Roach, R. C., 1995, High-altitude medicine. In: PS Auerbach (Ed.) Wilderness Medicine: management of wilderness and environmental emergencies, 3rd edn St Louis: Mosby, 1–37.
  • Windsor, J. S., Milledge , J. S., Rodway G. W., 2008, The effect of ambient temperature on the use of supplemental oxygen at high altitude. Wilderness Environ Med. Summer, 19, 143–144.
  • Roach, R. C., Hackett, P. H., 2001, Frontiers of hypoxia research: acute mountain sickness. Journal of Experimental Biology, 204, 3161–3170.
  • Botella, D., Martinezcosta, R., 1998, High altitude retinal haemorrhages in the expeditions to 8,000 meter peaks. A study of 10 cases. Med Clin (Barc), 110, 457–461.
  • Frayser, R., Houston, C., Bryan, A., 1970, Retinal haemorrhage at high altitude. New England Journal of Medicine, 282, 1183–1184.
  • McFadden, D., Houston, C., Sutton, J., Powles, A., 1981, High-altitude retinopathy. Journal of the American Medical Association, 245, 581–586.
  • Siato, S., Aso, C., Kanal, M., 2000, Experimental use of a transportable hyperbaric chamber durable for 15 psi at 3,700 meters above sea level. Wilderness & Environmental Medicine, 11, 21–24.
  • Dart, T. S., Butler, W., 1998, Towards new paradigms for the treatment of hypobaric decompression sickness. Aviation, Space, and Environmental Medicine, 69, 403–409.
  • Muehlberger, P. M., Pilmanis, A. A., Webb, J. T., Olson, J. E., 2004, Altitude decompression sickness symptom resolution during descent to ground level. Aviation, Space, and Environmental Medicine, 75, 496–499.
  • Al-Waili, N., Butler, G., 2006, Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. The ScientificWorldJournal, 3, 425–441.
  • Boerema, I., Meyne, N. G., Brummelkamp, W. K., Bouma, S., Mensch, M. H., Kamermans, F., Sternhanf, M., Van Aaldern, W., 1960, Life without blood: a study of the influence of high atmospheric pressure and hypothermia on dilution of blood. Journal of Cardiovascular Surgery, 1, 133–146.
  • Sukoff, M. H., Ragatz, R. E., 1982, Hyperbaric oxygenation for the treatment of acute cerebral edema. Neurosurgery, 10, 29–38.
  • Mink, R. B., Dutka, A. J., 1995, Hyperbaric oxygen after global cerebral ischemia in rabbits does not promote brain lipid peroxidation. Critical Care Medicine, 23, 1398–1404.
  • Thom, S. R., 1993, Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicology and Applied Pharmacology, 123, 248–256.
  • Mink, R. B., Dutka, A. J., 1995, Hyperbaric oxygen after global cerebral ischemia in rabbits reduces brain vascular permeability and blood flow. Stroke, 26, 2307–2312.
  • Weinstein, P. R., Hameroff, S. R., Johnson, P. C., Anderson, G. G., 1986, Effect of hyperbaric oxygen therapy or dimethyl sulfoxide on cerebral ischemia in unanesthetized gerbils. Neurosurgery, 18, 528–532.
  • Sunami, K., Takeda, Y., Hashimoto, M., Hirakawa, M., 2000, Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery. Critical Care Medicine, 28, 2831–2836.
  • Burt, J. T, Kapp, J.P., Smith, R. R., 1987, Hyperbaric oxygen and cerebral infarction in the gerbil. Surgical Neurology, 28, 265–268.
  • Jiang, J., Tyssebotn, I., 1997, Cerebrospinal fluid pressure changes after acute carbon monoxide poisoning and therapeutic effects of normobaric and hyperbaric oxygen in conscious rats. Undersea Hyperbaric Medicine, 24, 245–254.
  • Bartsch, P., Merki, B., Hofstetter, D., Maggiorini, M., Kayser, B., Oelz, O., 1993, Treatment of acute mountain sickness by simulated descent: a randomised control trial. British Medical Journal, 306, 1098–1101.
  • Harry, J. P., Jean, D., Kayser, B., Bartsch, P., 1992, Effect of a 3-h recompression at 220 mbar on AMS during climbing Mont-Blanc. International Journal of Sports Medicine, 13, 83.
  • Davis, J. C., Sheffieldm P. J., Schuknecht, L., Dunn, J. M., Douglas, G., Anderson, G. K., 1977, Altitude decompression sickness: hyperbaric therapy results in 145 cases. Aviation, Space, and Environmental Medicine, 48, 722–730.
  • Allan, G. M., Kenny, D., 2003, High-altitude decompression illness: case report and discussion. Canadian Medical Association Journal, 169, 803–807.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.